Dna X Inc (SONM)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Dna X Inc Stock (SONM) Company Profile

Technology (784)

650-378-8100

4445 EASTGATE MALL, SAN DIEGO, TX

Prossima data di guadagno

Ultimi documenti SEC

SONM's Discussions on Twitter

Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SONM Dna X Inc	3.03	4.66M	27.40M	-17.12M	-24.99M	-106.89
MSFT Microsoft Corp	492.73	3.67T	318.27B	125.22B	72.92B	16.79
ORCL Oracle Corp	162.03	468.13B	67.36B	17.31B	-23.69B	5.8248
PLTR Palantir Technologies Inc	169.98	409.24B	5.22B	2.29B	2.69B	0.8876
CRWD Crowdstrike Holdings Inc	208.97	215.05B	5.09B	-24.89M	1.43B	-0.0471
FTNT Fortinet Inc	157.42	115.54B	7.11B	1.95B	2.44B	2.5883

Dna X Inc Stock (SONM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2019-10-31	Downgrade	Oppenheimer	Outperform → Perform
2019-07-18	Iniziato	B. Riley FBR	Buy
2019-07-09	Aggiornamento	National Securities	Neutral → Buy
2019-06-10	Iniziato	National Securities	Neutral
2019-06-04	Iniziato	Lake Street	Buy
2019-06-04	Iniziato	Oppenheimer	Outperform

Mostra tutto

Dna X Inc Borsa (SONM) Ultime notizie

Dna X Inc Azioni (SONM) Dati Finanziari

Dna X Inc (SONM)

Dna X Inc Stock (SONM) Company Profile

Compare SONM vs MSFT, ORCL, PLTR, CRWD, FTNT

Dna X Inc Stock (SONM) Upgrades & Downgrades

Dna X Inc Borsa (SONM) Ultime notizie

Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News

Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail

DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView

How DNA's Double Helix Structure Was Discovered - Britannica

SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn

Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail

DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView

DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan

Restriction-enzyme DNA fingerprinting method explained - Britannica

DNA X: Q2 Earnings Snapshot - AOL.com

DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times

DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade

DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView

SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView

DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan

C&F Financial Corporation Announces Quarterly Dividend - The Manila Times

Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times

VVC Exploration Corporation Files Annual Financial Statements - The Manila Times

DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan

DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn

12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga

Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - Vinanet

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st

Sonim Technologies delays quarterly filing amid consolidation - TipRanks

DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan

SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView

Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com

DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan

DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan

DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn

Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance

Star Wars Zero Company is a very safe XCOM descendant, but its most interesting parts are found in its Midnight Suns DNA - PC Gamer

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛

SONM Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesPost-Announcement Reaction - vinanet.vn

DNA X, Inc. announced that it has received $5.000004 million in funding from DNA Holdings Venture, Inc. - marketscreener.com

DNA X Inc. (SONM) Slips 1.69% as Shares Test Key Support at $3.60Synthetic Short - vinanet.vn

Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK

Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan

DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView

VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK

VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times

12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga

DNA Sequencing Market Size to Hit USD 57.39 Billion by 2035 - Precedence Research

SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et

Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail

12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga

DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart

DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView

YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times

SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et

Dna X Inc Azioni (SONM) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SONM